Product approvals in regenerative medicine and rare diseases are among the highlights in our recap of recent FDA regulatory decisions.

Since the start of 2020, Eli Lilly’s (NYSE: LLY) stock price chart has been straight up and to the right, up 489.81% and ...

Earlier this year, The Lancet Respiratory Medicine reported staggering global estimates for the number of people aged 30–69 years who are affected by obstructive sleep apnoea (OSA). The figure of ...